P.M. Rao's research while affiliated with Long Island University and other places

Publication (1)

Article
Purpose The purpose of this paper, focusing mainly on India – and a lesser extent on China – is to examine, broadly, two related issues concerning the rise of pharmaceutical industry in the emerging economies: the strategic response of the emerging‐country pharmaceutical firms to the new patent regime that recognizes and enforces product patents; a...

Citations

... Foreign businesses possessed almost 99 percent of all pharmaceutical patents in India at the time, and domestic Indian medicine costs were among the highest in the world [3]. From the 1960s until the government implemented policies emphasizing self-sufficiency and employing local production the pharma business in India remained import-dependent (Rao, 2008) [4]. The stringent government reforms including the elimination of product patents through the Patent Act, 1970 on pharmaceuticals, agricultural products, and atomic energy and price limitations on some formulations and bulk drugs through the Drug Price Control Order (DPCO), 1970 led to the withdrawal of MNCs from Indian Pharma market. ...